Printer Friendly

MEDIMMUNE ANNOUNCES APPOINTMENT OF DAVID M. MOTT, VICE PRESIDENT, DEVELOPMENT AND PLANNING

 MEDIMMUNE ANNOUNCES APPOINTMENT OF DAVID M. MOTT,
 VICE PRESIDENT, DEVELOPMENT AND PLANNING
 GAITHERSBURG, Md., April 28 /PRNewswire/ -- MedImmune, Inc. (NASDAQ: MEDI) today announced the appointment of David M. Mott, to the newly created position of vice president, development and planning. His most recent position was vice president, corporate finance, Smith Barney, Harris Upham & Co. Inc. Mott will report to MedImmune's President and Chief Executive Officer, Wayne T. Hockmeyer.
 "David Mott's skills and experience will integrate well into the management team at MedImmune," Dr. Hockmeyer said. "He is joining the Company at an exciting point in MedImmune's development -- with CytoGam(TM) in the marketplace and technology that is being converted into important new health care products."
 MedImmune, Inc. was founded in 1988 to develop, manufacture and market therapeutics and vaccines for the treatment and prevention of infectious diseases. The company's corporate headquarters are in Gaithersburg.
 -0- 4/28/92
 /CONTACT: Wayne T. Hockmeyer, president and chief executive officer of MedImmune, 301-417-0770; or Fredric Spar of Kekst and Company, 212-593-2655, for MedImmune/
 (MEDI) CO: MedImmune Inc. ST: Maryland IN: MTC SU: PER


TS -- NY063 -- 3717 04/28/92 11:20 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 28, 1992
Words:189
Previous Article:CAPSTEAD MORTGAGE ANNOUNCES TWO CMOs TOTALING $400 MILLION
Next Article:INTERCARGO REPORTS RECORD FIRST QUARTER EARNINGS NET INCOME UP 62 PERCENT


Related Articles
MEDIMMUNE'S RESPIVIR(TM) TO BE REVIEWED BY FDA ADVISORY COMMITTEE
MEDIMMUNE DISCONTINUES NEGOTIATIONS TO ACQUIRE MELVILLE BIOLOGICS FROM THE NEW YORK BLOOD CENTER
MEDIMMUNE ANNOUNCES PROMOTION OF DAVID M. MOTT TO PRESIDENT AND CHIEF OPERATING OFFICER
MedImmune to Promote David Mott to Chief Executive Officer; Wayne Hockmeyer to Continue as Chairman of the Board.
MedImmune to Make CEO Transition Effective October 1, 2000.
MedImmune Appoints CFO, Promotes Several Senior Executives.
MedImmune Promotes Several Senior Executives and Appoints New Vice President, Oncology Sales & Marketing.
MedImmune Adds Substantial Expertise to Commercial Organization With Appointment of Two New Vice Presidents.
MedImmune Fills Senior Marketing and Sales Post.
MedImmune Further Expands its Commercial Organization Expertise With Appointment of Two Additional Vice Presidents.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters